Pacer Advisors Inc. lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 51,834 shares of the healthcare conglomerate’s stock after selling 4,577 shares during the period. Pacer Advisors Inc.’s holdings in UnitedHealth Group were worth $19,286,000 at the end of the most recent quarter.
Several other hedge funds have also recently modified their holdings of the stock. Accel Wealth Management acquired a new position in UnitedHealth Group in the fourth quarter valued at $26,000. Front Row Advisors LLC boosted its stake in UnitedHealth Group by 288.0% in the third quarter. Front Row Advisors LLC now owns 97 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 72 shares in the last quarter. Sage Private Wealth Group LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at $36,000. IronBridge Private Wealth LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at $37,000. Finally, Costello Asset Management INC boosted its stake in UnitedHealth Group by 500.0% in the fourth quarter. Costello Asset Management INC now owns 120 shares of the healthcare conglomerate’s stock valued at $42,000 after acquiring an additional 100 shares in the last quarter. Hedge funds and other institutional investors own 86.03% of the company’s stock.
Shares of UNH stock traded up $0.07 during trading hours on Thursday, hitting $365.71. The company’s stock had a trading volume of 33,665 shares, compared to its average volume of 3,420,935. The business has a fifty day moving average of $351.44 and a 200-day moving average of $339.34. The stock has a market cap of $345.71 billion, a price-to-earnings ratio of 21.00, a P/E/G ratio of 1.55 and a beta of 0.74. UnitedHealth Group Incorporated has a twelve month low of $246.26 and a twelve month high of $380.50. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.59.
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 23rd. Investors of record on Monday, March 15th were given a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, March 12th. This represents a $5.00 dividend on an annualized basis and a yield of 1.37%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 33.09%.
A number of brokerages have recently commented on UNH. Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $404.00 to $409.00 and gave the company a “buy” rating in a report on Thursday, January 21st. Barclays reaffirmed a “buy” rating and issued a $405.00 target price on shares of UnitedHealth Group in a report on Sunday, January 17th. Bank of America reaffirmed a “buy” rating and issued a $415.00 target price on shares of UnitedHealth Group in a report on Thursday, January 21st. SVB Leerink increased their price target on shares of UnitedHealth Group from $378.00 to $390.00 and gave the stock an “outperform” rating in a report on Monday, December 14th. Finally, Truist increased their price target on shares of UnitedHealth Group from $400.00 to $420.00 in a report on Tuesday, January 5th. Five research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the stock. UnitedHealth Group currently has an average rating of “Buy” and an average target price of $387.82.
In related news, CAO Thomas E. Roos sold 619 shares of the firm’s stock in a transaction that occurred on Tuesday, February 9th. The shares were sold at an average price of $323.90, for a total transaction of $200,494.10. Following the sale, the chief accounting officer now owns 31,908 shares in the company, valued at $10,335,001.20. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, March 15th. The stock was sold at an average price of $353.32, for a total transaction of $1,413,280.00. Following the sale, the director now owns 153,953 shares in the company, valued at approximately $54,394,673.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 9,619 shares of company stock worth $3,292,774. 0.80% of the stock is owned by company insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
Recommended Story: What is the Coverage Ratio?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.